NHD & partners start multi-million project
Early tracing of SARS-CoV2-infected individuals at the stage when there are no clinical symptoms, is crucial to prevent further transmission.
Based on existing platform technology NH DyeAGNOSTICS with scientific and industrial partners are developing a test for rapid, portable SARS-CoV2 diagnostics.
Why is the development of the quick test particularly important?
- • allows to perform quick and cost-efficient point-of-care testing
- • allows regular screening in the groups of high-risk individuals
- • simple stripe-test, does not require specialized expensive machines,
reagents or trained staff
In alliance with our cooperation partners we expect to bring the product to the market within 6-8 months. The project is co-funded by the BMBF.